Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medigen BiotechnologyROCO:3176 +0.99%58 Days Inventory is 401.74 as of Dec. 2025, which is 96% above its 10-year median of 204.55. GuruFocus rates ROCO:3176 with a GF Score™ of 58/100 and a GF Value™ of NT$49.65 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 638 Biotechnology companies, Medigen Biotechnology ranks worse than 73.67% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Medigen Biotechnology's Inventory Turnover for the
three
months ended in Dec. 2025 was 0.23.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Medigen Biotechnology's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 1.91.
Medigen Biotechnology (ROCO:3176) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Medigen Biotechnology's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Medigen Biotechnology's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Medigen Biotechnology Days Inventory Related Terms
Medigen Biotechnology Days Inventory Historical Data
* Premium members only.
The historical data trend for Medigen Biotechnology's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:3176 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Medigen Biotechnology's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medigen Biotechnology Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Medigen Biotechnology's Days Inventory distribution charts can be found below:
* The bar in red indicates where Medigen Biotechnology's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medigen Biotechnology (ROCO:3176) has a Days Inventory of 401.74 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Medigen Biotechnology and its competitors. This is 96% above median its historical median of 204.55. Over the past decade, Medigen Biotechnology's Days Inventory has ranged from 143.28 to 418.61. According to the industry distribution chart, Medigen Biotechnology ranks #470 out of 638 companies in the Biotechnology industry, placing it in the top 73.7%.
Is Medigen Biotechnology's Days Inventory too high?
Medigen Biotechnology's current Days Inventory of 401.74 is 96% above median its 10-year median of 204.55. Over the past 10 years, this metric has ranged from a low of 143.28 to a high of 418.61. The Biotechnology industry median Days Inventory is 183.20. Medigen Biotechnology's value of 401.74 is 119.3% above this industry median. Based on the distribution chart, Medigen Biotechnology ranks #470 out of 638 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Medigen Biotechnology has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medigen Biotechnology's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Medigen Biotechnology ranks #470 out of 638 companies for Days Inventory. This places Medigen Biotechnology in the lower half of its industry. The industry median Days Inventory is 183.20. Medigen Biotechnology's value of 401.74 is 119.3% above this benchmark. Historically, Medigen Biotechnology's own Days Inventory has ranged from 143.28 to 418.61 over the past decade. While the company's 10-year median is 204.55 vs. the industry median of 183.20, Medigen Biotechnology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medigen Biotechnology's current Days Inventory of 401.74 is 119.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Medigen Biotechnology and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medigen Biotechnology's current Days Inventory is 401.74, which is 96% above median its own 10-year median of 204.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medigen Biotechnology stock overvalued right now?
Based on GuruFocus' analysis, Medigen Biotechnology (ROCO:3176) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$49.65, compared to a current price of NT$35.75 — trading 28% below its estimated fair value. The current Days Inventory is 401.74, which is 96% above median its 10-year median of 204.55 and 119.3% above the Biotechnology industry median of 183.20. Medigen Biotechnology's overall GF Score™ is 58/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Medigen Biotechnology (ROCO:3176), the current Days Inventory is 401.74 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medigen Biotechnology (ROCO:3176) Overvalued in 2026?
Based on GuruFocus' analysis, Medigen Biotechnology stock appears to be undervalued.
The current stock price of NT$35.75 is trading 28% below its estimated GF Value™ of NT$49.65.
GuruFocus considers Medigen Biotechnology to be Modestly Undervalued.
Key valuation signals for ROCO:3176:
Days Inventory: 401.74 (96% above median its 10-year median of 204.55)
GF Value™: NT$49.65 vs. price of NT$35.75 (28% below fair value)
Industry Position: 119.3% above the Biotechnology median (#470 of 638)
No single metric tells the full story. See the ROCO:3176 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medigen Biotechnology Corp is engaged in the research and development of new drugs and vaccines, cytotherapy, nucleic acid testing, and the production and sales of generic drugs, aesthetic medicine products and vaccine-related products. Its segments are the Nucleic acid department, the New drug and vaccine research and development segment, the Cytotherapy department, and the Generic drug, aesthetic medicine product and dietary supplement segment: responsible for production and sales and relevant services of western medicine, aesthetic medicine product, and dietary supplement. The majority of revenue is derived from generic drugs, aesthetic medicine products, and the dietary supplement segment. Geographically, it operates in Taiwan, China, and Other countries with revenue from Taiwan.
58GF Score
Get the complete analysis for ROCO:3176
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:3176 has been successfully added to your 
